Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

335
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
335
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.7K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.7K
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

428
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
428
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

898
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
898
Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

492
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
492
Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model01:14

Pharmacodynamic Models: Link Model and Systems Pharmacodynamic Model

151
The link model is a fundamental pharmacokinetic-pharmacodynamic (PK–PD) approach to account for delayed drug responses when the observed effect does not immediately correlate with the drug's plasma concentration peak. This delay is mathematically addressed by introducing an effect compartment concentration, Ce, which is kinetically linked to the plasma concentration, Cp, via a first-order rate constant, ke0. The linkage allows for a more accurate prediction of drug effects over time. A...
151

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrated Population Pharmacokinetic Analysis of Intravitreal Aflibercept Drug Products.

CPT: pharmacometrics & systems pharmacology·2026
Same author

Erratum to "In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution" [Int. J. Pharm. 699 (2026) 126952].

International journal of pharmaceutics·2026
Same author

In vitro - In vivo correlation modeling of an oxcarbezapine extended-release formulation using numerical deconvolution.

International journal of pharmaceutics·2026
Same author

Population Pharmacokinetics of Dupilumab in Adults, Adolescents, and Children With Eosinophilic Esophagitis.

Clinical pharmacology and therapeutics·2026
Same author

A Phase I Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Liposomal Bupivacaine for Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy.

Journal of clinical pharmacology·2024
Same author

Integrated Exposure-Response of Dupilumab in Children, Adolescents, and Adults With Atopic Dermatitis Using Categorical and Continuous Efficacy Assessments: A Population Analysis.

Pharmaceutical research·2023

Related Experiment Video

Updated: May 6, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.0K

Modeling of pharmacokinetic systems using stochastic deconvolution.

Maziar Kakhi1, Jason Chittenden

  • 1Food and Drug Administration, Silver Spring, Maryland, 20993.

Journal of Pharmaceutical Sciences
|November 1, 2013
PubMed
Summary

Stochastic deconvolution accurately infers drug absorption profiles using a hybrid modeling approach. This method enhances pharmacokinetic (PK) modeling, even for complex systems where full mechanistic understanding is lacking.

Keywords:
absorptionin silico modelingin vitro/in vivo correlation (IVIVC)mathematical modelsnonlinear mixed effects (NLME) modelingpopulation pharmacokineticssimulationsstochastic deconvolution

More Related Videos

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.7K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.3K

Related Experiment Videos

Last Updated: May 6, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

9.0K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.7K
Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study
20:24

Characterization of Complex Systems Using the Design of Experiments Approach: Transient Protein Expression in Tobacco as a Case Study

Published on: January 31, 2014

16.3K

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Mathematical Modeling
  • Computational Biology

Background:

  • Mechanistic knowledge is often incomplete in complex biological systems.
  • Pharmacokinetic (PK) modeling requires robust methods for systems with unknown dynamics.
  • In vitro-in vivo correlation (IVIVC) modeling benefits from accurate absorption profiling.

Purpose of the Study:

  • To introduce and validate "stochastic deconvolution" as a diagnostic tool for PK model development.
  • To demonstrate the ability of stochastic deconvolution to infer predefined absorption profiles from simulated data.
  • To assess the performance of stochastic deconvolution in complex PK scenarios.

Main Methods:

  • Coupling ordinary differential equations for PK with a Wiener process for absorption rate.
  • Embedding the model within a nonlinear mixed-effects population PK framework.
  • Investigating PK systems with Michaelis-Menten kinetics and enterohepatic circulation.

Main Results:

  • Stochastic deconvolution accurately reproduced simulated absorption profiles.
  • The method succeeded in scenarios where linear models would fail.
  • Computational times were manageable on standard hardware.

Conclusions:

  • Stochastic deconvolution offers an efficient and accurate strategy for PK model development with incomplete mechanistic data.
  • This approach can inform mapping functions for IVIVC modeling.
  • The method is robust for complex PK systems, including nonlinear kinetics and enterohepatic circulation.